Related Experiment Videos

Akt enhances Mdm2-mediated ubiquitination and degradation of p53

Yoko Ogawara1, Shohei Kishishita, Toshiyuki Obata

  • 1Institute of Molecular and Cellular Biosciences, University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-0032, Japan.

Insights

The Akt pathway reduces p53 protein levels by enhancing Mdm2-mediated degradation. Akt phosphorylates Mdm2 at Ser186, increasing p53 ubiquitination and promoting apoptosis resistance.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Biochemistry

Background:

  • p53 is crucial for DNA damage-induced apoptosis.
  • The phosphatidylinositol 3-OH-kinase-Akt pathway is known to inhibit p53 activity.
  • The precise mechanisms by which Akt influences p53 remain unclear.

Purpose of the Study:

  • To elucidate the mechanisms by which the Akt pathway affects p53 protein levels and function.
  • To investigate the role of Mdm2, a p53 ubiquitin ligase, in Akt-mediated regulation of p53.

Main Methods:

  • Investigated the effect of Akt expression on p53 protein levels and degradation.
  • Analyzed Mdm2 phosphorylation at Ser186 induced by Akt or serum.
  • Assessed Mdm2 ubiquitination of p53 in response to Akt signaling.
  • Utilized site-directed mutagenesis to replace Ser186 with Alanine in Mdm2.

Main Results:

  • Akt expression reduced p53 protein levels, partly by enhancing p53 degradation.
  • Akt and serum treatment induced Mdm2 phosphorylation at Ser186.
  • Akt-mediated Mdm2 phosphorylation at Ser186 enhanced p53 ubiquitination.
  • Mutation of Ser186 in Mdm2 rendered it resistant to Akt-induced p53 ubiquitination and degradation.

Conclusions:

  • Akt enhances Mdm2's ubiquitination-promoting function through phosphorylation of Mdm2 at Ser186.
  • This Akt-mediated mechanism leads to reduced p53 protein levels.
  • The findings provide insights into how Akt signaling promotes cell survival, proliferation, and tumorigenesis.

Related Concept Videos